Evidence map›Paper›PMID 42120420›Full record

ArticleNPJ systems biology and applications2026

Interpreting MALDI imaging data for rare types of ampullary cancer using machine learning.

Patrick M Jensen, Jan Lellmann, Christian Sperling, Frieder Meier, Marius Distler, Daniela E Aust, Herbert Thiele, Pia Hönscheid

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Patrick M JensenDepartment of Applied Mathematics and Computer Science, Technical University of Denmark, Lyngby, Denmark. patmjen@dtu.dk.
Jan LellmannInstitute of Mathematics and Image Computing, University of Lübeck, Lübeck, Germany.
Christian SperlingInstitute for Pathology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Frieder MeierInstitute for Pathology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Marius DistlerDepartment of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Daniela E AustInstitute for Pathology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Herbert ThieleFraunhofer Institute for Digital Medicine MEVIS, Lübeck, Germany.
Pia HönscheidInstitute for Pathology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Pia.Hoenscheid@ukdd.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare tumor diseases are difficult to diagnose and there is a lack of routine diagnostic procedures. Approaches must be found that allow comprehensive identification and evaluation of prognostic relevant target proteins or transcripts. Analyzing rare ampullary cancer, respectively, to their prognosis and predictive factors by machine learning (ML) based matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) imaging is a first step towards providing new solutions for diagnostics of those cancer samples. In this study, we investigated a cohort of ampullary adenocarcinomas, including intestinal, pancreatic and cases of unknown subtypes, to identify differences in the proteome. Human formalin-fixed paraffin-embedded (FFPE) tissues were pathologically assessed, immunohistological stained, MALDI Imaging detected, and ML-related analyzed. We enable MALDI imaging as a diagnostic complement for immunohistochemical analysis and provide a MALDI Imaging neural network for broad application in tumor diagnostics. Moreover, using tools from ML model explainability, we determined a small subset of influential m/z-values from the trained models. The transformation of locally established ML networks dependent on one proteomic application source to other similar application sources (without peak picking or other pre-processing) is the basis for future rare cancer patient data collection.

Indexed as

Ampulla of VaterCommon Bile Duct NeoplasmsMachine LearningSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAdenocarcinomaFemaleHumansImmunohistochemistryMalePancreatic NeoplasmsProteomics

Identifiers

PMID42120420
PMCPMC13388676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.